FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 341:1698-1700 November 25, 1999 Number 22 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Mofenson, L. M. PubMed Citation

To the Editor: In the August 5 issue, Mofenson et al.¹ conclude that antiretroviral therapy "should be recommended to all infected pregnant women regardless of their HIV-1 [human immunodeficiency virus type 1] RNA levels," and Garcia et al.² conclude that zidovudine therapy has "demonstrated efficacy in reducing the risk of transmission regardless of the maternal HIV-1 RNA levels." Neither study provides sufficient evidence to support these statements.

We updated the results of a meta-analysis of the predictive value of viral load for perinatal HIV-1 transmission³ with data presented by Garcia et al. Among 10 studies of pregnant women in the . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.